Literature DB >> 8920867

T cell response to Epstein-Barr virus transactivators in chronic rheumatoid arthritis.

E Scotet1, J David-Ameline, M A Peyrat, A Moreau-Aubry, D Pinczon, A Lim, J Even, G Semana, J M Berthelot, R Breathnach, M Bonneville, E Houssaint.   

Abstract

Rheumatoid arthritis is a multistep disorder associated with autoimmune features of yet unknown etiology. Implication of viruses such as Epstein-Barr virus (EBV) in rheumatoid arthritis pathogenesis has been suspected on the basis of several indirect observations, but thus far, a direct link between EBV and rheumatoid arthritis has not been provided. Here we show that a large fraction of T cells infiltrating affected joints from a patient with chronic rheumatoid arthritis recognizes two EBV transactivators (BZLF1 and BMLF1) in a major histocompatibility complex-restricted fashion. Responses to these EBV antigens by synovial lymphocytes from several other chronic rheumatoid arthritis patients were readily detectable. Thus these results suggest a direct contribution of EBV to chronic rheumatoid arthritis pathogenesis. They also demonstrate for the first time the occurrence of T cell responses against EBV transactivating factors, which might be central in the control of virus reactivation.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8920867      PMCID: PMC2192863          DOI: 10.1084/jem.184.5.1791

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  37 in total

1.  Predominantly T-cell infiltrate in rheumatoid synovial membranes.

Authors:  J A Van Boxel; S A Paget
Journal:  N Engl J Med       Date:  1975-09-11       Impact factor: 91.245

2.  Altered regulation of Epstein-Barr virus induced lymphoblast proliferation in rheumatoid arthritis lymphoid cells.

Authors:  P A Bardwick; H G Bluestein; N J Zvaifler; J M Depper; J E Seegmiller
Journal:  Arthritis Rheum       Date:  1980-06

3.  Increased frequency of HLA-Cw3 and HLA-Dw4 in rheumatoid arthritis.

Authors:  A J McMichael; T Sasazuki; H O McDevitt; R O Payne
Journal:  Arthritis Rheum       Date:  1977-06

4.  Defective EBV-specific suppressor T-cell function in rheumatoid arthritis.

Authors:  G Tosato; A D Steinberg; R M Blaese
Journal:  N Engl J Med       Date:  1981-11-19       Impact factor: 91.245

5.  HLA-DR genotype risks in seropositive rheumatoid arthritis.

Authors:  L Legrand; G M Lathrop; A Marcelli-Barge; A Dryll; T Bardin; N Debeyre; J C Poirier; M Schmid; A Ryckewaert; J Dausset
Journal:  Am J Hum Genet       Date:  1984-05       Impact factor: 11.025

6.  Elevated levels of antibodies to Epstein-Barr virus antigens in sera and synovial fluids of patients with rheumatoid arthritis.

Authors:  M A Alspaugh; G Henle; E T Lennette; W Henle
Journal:  J Clin Invest       Date:  1981-04       Impact factor: 14.808

7.  Dw subtypes of DR4 in rheumatoid arthritis: evidence for a preferential association with Dw4.

Authors:  D Zoschke; M Segall
Journal:  Hum Immunol       Date:  1986-01       Impact factor: 2.850

8.  Association of the B-cell alloantigen DRw4 with rheumatoid arthritis.

Authors:  P Stastny
Journal:  N Engl J Med       Date:  1978-04-20       Impact factor: 91.245

9.  Recognition of a mycobacteria-specific epitope in the 65-kD heat-shock protein by synovial fluid-derived T cell clones.

Authors:  J S Gaston; P F Life; P J Jenner; M J Colston; P A Bacon
Journal:  J Exp Med       Date:  1990-03-01       Impact factor: 14.307

10.  Human Epstein-Barr virus (EBV)-specific cytotoxic T lymphocytes home preferentially to and induce selective regressions of autologous EBV-induced B cell lymphoproliferations in xenografted C.B-17 scid/scid mice.

Authors:  J F Lacerda; M Ladanyi; D C Louie; J M Fernandez; E B Papadopoulos; R J O'Reilly
Journal:  J Exp Med       Date:  1996-03-01       Impact factor: 14.307

View more
  49 in total

Review 1.  T cell receptor usage in autoimmune disease.

Authors:  P Moss; J Bell
Journal:  Springer Semin Immunopathol       Date:  1999

2.  CD8(+) T-cell selection, function, and death in the primary immune response in vivo.

Authors:  M F Callan; C Fazou; H Yang; T Rostron; K Poon; C Hatton; A J McMichael
Journal:  J Clin Invest       Date:  2000-11       Impact factor: 14.808

3.  Crossreactive recognition of viral, self, and bacterial peptide ligands by human class I-restricted cytotoxic T lymphocyte clonotypes: implications for molecular mimicry in autoimmune disease.

Authors:  I S Misko; S M Cross; R Khanna; S L Elliott; C Schmidt; S J Pye; S L Silins
Journal:  Proc Natl Acad Sci U S A       Date:  1999-03-02       Impact factor: 11.205

4.  Elevated immunoglobulin G antibodies to the proline-rich amino-terminal region of Epstein-Barr virus nuclear antigen-2 in sera from patients with systemic connective tissue diseases and from a subgroup of Sjögren's syndrome patients with pulmonary involvements.

Authors:  M Yamazaki; R Kitamura; S Kusano; H Eda; S Sato; M Okawa-Takatsuji; S Aotsuka; K Yanagi
Journal:  Clin Exp Immunol       Date:  2005-03       Impact factor: 4.330

5.  Epstein-Barr virus serologic abnormalities and risk of rheumatoid arthritis among women.

Authors:  Barbara L Goldstein; Lori B Chibnik; Elizabeth W Karlson; Karen H Costenbader
Journal:  Autoimmunity       Date:  2011-10-20       Impact factor: 2.815

6.  Accessing Epstein-Barr virus-specific T-cell memory with peptide-loaded dendritic cells.

Authors:  I V Redchenko; A B Rickinson
Journal:  J Virol       Date:  1999-01       Impact factor: 5.103

7.  Evaluating candidate autoantigens in rheumatoid arthritis.

Authors:  A P Cope; G Sønderstrup
Journal:  Springer Semin Immunopathol       Date:  1998

8.  Decreased T cell precursor frequencies to Epstein-Barr virus glycoprotein Gp110 in peripheral blood correlate with disease activity and severity in patients with rheumatoid arthritis.

Authors:  E Toussirot; D Wendling; P Tiberghien; J Luka; J Roudier
Journal:  Ann Rheum Dis       Date:  2000-07       Impact factor: 19.103

Review 9.  T-cell memory: lessons from Epstein-Barr virus infection in man.

Authors:  A B Rickinson; M F Callan; N E Annels
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2000-03-29       Impact factor: 6.237

10.  Selection of Epstein-Barr virus specific cytotoxic T lymphocytes can be performed with B lymphoblastoid cell lines created in serum-free media.

Authors:  G Gallot; S Vollant; R Vivien; B Clémenceau; C Ferrand; P Tiberghien; J Gaschet; N Robillard; H Vié
Journal:  Clin Exp Immunol       Date:  2006-04       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.